News
Sun Pharma announces FDA tentative approval for generic Cymbalta
Sun Pharmaceutical Industries Ltd. announced US FDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a...
Clinical Trials
Bayer and Regeneron Report Positive Top-Line Results of Two Phase 3 Studies
Bayer HealthCare and Regeneron Pharmaceuticals, Inc. announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration...
Press Releases
NanoString Launches First Simple and Precise Approach to Detect Hundreds of Genetic Copy Variants in a Single Multiplexed Reaction
NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological...
News
Lilly and Acrux Receive FDA Approval for Axiron Topical Solution CIII
Eli Lilly and Company and Acrux announced that the U.S. FDA has approved Axiron topical solution CIII for replacement therapy in men for certain...
Press Releases
Merrion Pharmaceuticals Plc announces commencement of feasibility and option agreement with Rebel Pharmaceuticals
Merrion Pharmaceuticals Plc, a publicly listed product development company, announced the commencement of an oral drug delivery feasibility and option agreement with Rebel Pharmaceuticals,...
News
VYTORIN the cholesterol-lowering medicine from Merck
In a new investigational study of VYTORIN, the cholesterol-lowering medicine from Merck (known as MSD outside the US and Canada), VYTORIN 10/20 mg reduced...
Clinical Trials
Reata and Abbott Announce Positive Phase 2b Study Results for Bardoxolone Methyl
Abbott Park, Illinois-Reata Pharmaceuticals and Abbott today announced data from a Phase 2b study which suggests that bardoxolone methyl, an investigational treatment for chronic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read